Clinical Trial Site — New York, New York

Clinical Trial Site is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Clinical Trial Site has participated in 61 clinical trials with 26 currently active.

Therapeutic areas: Acute Hepatic Porphyria, Celiac Disease, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy.

Sponsors: Alnylam Pharmaceuticals, Provention Bio, a Sanofi Company, AMAG Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Trial Site?

Clinical Trial Site has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Trial Site conducted?

Clinical Trial Site has 61 clinical trials on record, with 26 currently active. Their work covers Acute Hepatic Porphyria, Celiac Disease, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy.

Is Clinical Trial Site accredited by Crixeo Health?

Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.